Scale-up of collaborative TB/HIV activities in Guyana

Baker, Brian J.; Peterson, Brandy; Mohanlall, Jeetendra; Singh, Shanti; Hicks, Collene; Jacobs, Ruth; Ramos, Ruth; Allen, Barbara; Pevzner, Eric.
Rev Panam Salud Publica ; 41, ene. 2017
Artículo en Inglés | PAHOIRIS | ID: phr-33836

Documentos relacionados

  1. Simplifying Rifapentine Dosing for Tuberculosis Treatment and Prevention.
  2. No evidence of increased risk of acquired rifampin resistance.
  3. Current Status of Latent Tuberculosis Infection Treatment Among Pediatric Patients in Korea: Prescription and Treatment Completion.
  4. High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus.
  5. Treatment of latent tuberculosis infection in patients receiving biologic agents.
  6. Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women With HIV.
  7. Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review.
  8. Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study.
  9. Benefit of treatment of latent tuberculosis infection in individual patients.
  10. Ramadan and Culturally Competent Care: Strengthening Tuberculosis Protections for Recently Resettled Muslim Refugees.